Maitake
Best-in-class: Maitake Mushroom
A medicinal mushroom (beta-glucan 'D-fraction') used for immune support and healthy blood sugar.
Maitake quick facts
| Suggested dose | 1–3 g extract daily. |
| How often | Daily |
| Who it's for | Immune and blood-sugar/metabolic support. |
The immune data is preliminary; the glucose data is arguably more interesting and less discussed. Same fruiting-body-versus-mycelium quality issue as all medicinal mushrooms. Because it lowers blood glucose it matters alongside diabetes medication.
How Maitake actually works
The D-fraction is a beta-glucan with demonstrated NK-cell activation in preclinical work and small human studies. Maitake also has a separate and reasonably well-supported effect on insulin sensitivity, apparently through alpha-glucosidase inhibition and effects on glucose transport.
Where to get Maitake
Find Maitake on iHerb →The evidence for Maitake
Graded by what exists behind each claim.
✅ Clinically validated
- Beta-glucans support immune-cell activity; some studies show blood-sugar and metabolic benefits.
- Immune-modulating D-fraction is the studied component.
📊 Correlative data
- Traditional Japanese use as both food and medicine, and consumed at meaningful dietary scale, which is where the tolerability record comes from.
🧪 Theoretical / extrapolated benefits
- Dual immune + metabolic angle is promising.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Maitake actually does
Maitake's active material is a polysaccharide, and the first thing worth knowing is that it is not the same polysaccharide as the yeast beta-glucan sold two shelves along. Baker's yeast glucan is a beta-1,3 backbone carrying beta-1,6 branches De Marco Castro 2021. The fraction that made Grifola frondosa famous — the D-fraction — is described in the mushroom literature as a protein-bound glucan built the other way round, a beta-1,6 main chain with beta-1,3 branch points, sitting among a wider mixture of beta-glucans and heteroglycans in the fruiting body Wu 2021. Same monomer, opposite architecture, and architecture is the whole argument here.
Why architecture decides everything. The receptor that reads these molecules is Dectin-1, the gene CLEC7A, a C-type lectin on macrophages, monocytes, dendritic cells and neutrophils. Its cytoplasmic tail carries a single hemITAM motif; ligation recruits the kinase Syk, which drives the CARD9–Bcl-10–MALT1 module into NF-kappaB, with a second Syk-independent arm through Raf-1 Mata-Martinez 2022. What that receptor recognizes is a beta-1,3 run of a certain length in a certain conformation. A polymer whose beta-1,3 content sits in short branches off a beta-1,6 spine is a different ligand from one whose beta-1,3 content is the spine itself, and no maitake label has ever printed which it is selling.
The part almost nobody states. Dectin-1 does not signal well just by being occupied. It signals when it is clustered by a particulate ligand into a contact zone that physically excludes the bulky membrane phosphatases CD45 and CD148 — the phagocytic synapse. A dissolved glucan can bind the receptor and fail to produce that exclusion, which is why soluble and particulate preparations of chemically identical polysaccharide behave differently in the same assay Mata-Martinez 2022. Powdered fruiting-body extract in a capsule is somewhere on that spectrum and nobody has said where.
And the blood-sugar half is a separate molecule. The glucose-lowering work in this mushroom belongs to a different, more soluble fraction than the immune work, and the reviews treat them as distinct preparations Wu 2021. The dull explanation — a viscous soluble polysaccharide slowing carbohydrate absorption in the gut, no receptor involved — has never been separated from the interesting one in a human. That separation is a fasting-glucose curve with and without a viscosity-matched control fiber, and it does not exist.
Cell, rodent, human — and where it stops
In cells. The Dectin-1 and phagocytic-synapse work that underwrites every mushroom immune claim was done largely with yeast particles and purified yeast glucan, not with maitake proteoglucan Mata-Martinez 2022. The reprogramming experiments that made beta-glucan famous used Candida albicans cell wall material on isolated human monocytes and in mice, and showed the effect requires dectin-1 and Raf-1 Quintin 2012. Nothing in that chain is Grifola frondosa.
In people, once. There is one dose-ranging human trial of a maitake polysaccharide extract and it is worth reading properly. Thirty-four postmenopausal breast cancer patients took a liquid extract by mouth at 0.1 to 5 mg/kg twice daily for 3 weeks. Immune measures moved — the association was strong, p < 0.0005 — but the dose–response curve was non-monotonic: intermediate doses produced either enhancement or suppression depending on the readout Deng 2009. That is the opposite of the assumption every label makes.
The obstacle, and it runs the unusual way. Normally the complaint is that a trial used ten times the label dose. Here the label is above the entire tested range. At 70 kg, 0.1 to 5 mg/kg twice daily is roughly 14 mg to 700 mg of extract per day. A capsule label reading 1–3 g sits past the top of the only human dose ladder ever climbed, on a curve the trial itself found was not monotonic Deng 2009. Nobody has gone above 5 mg/kg to find out what happens next.
The second obstacle is who was in the room. Those 34 people were postmenopausal women after treatment for breast cancer, chosen because their immune measures had somewhere to move. A well 35-year-old buying this in October is not that person, and there is no trial of maitake for respiratory infection incidence in healthy adults at all.
Maitake — which form, and does it matter
D-fraction, MD-fraction, SX-fraction, or mushroom powder. These are four different products and only the first has the human trial. The D-fraction is a purified protein-bound glucan; the glucose-directed fraction is a separate preparation from the same mushroom Wu 2021. A bottle that says only “Maitake 500 mg” has told you which mushroom and nothing about which fraction.
Fruiting body against mycelium on grain. Most cheap mushroom supplements are mycelium grown on a sterilized grain substrate and milled with the grain still in it. The grain contributes starch, which is an alpha-glucan. A label claiming “polysaccharides 30%” is quoting a total that counts that starch, and total polysaccharide is not beta-glucan. The only number that means anything is a beta-glucan percentage from an assay that subtracts alpha-glucan enzymatically, and it is printed on a small minority of products.
What the trial actually gave. A liquid extract, dosed per kilogram of body weight Deng 2009. Nothing on the shelf is dosed per kilogram, and nothing on the shelf is that liquid. The site's own guidance to buy a fruiting-body extract standardized for beta-glucans is the right instinct — but be clear that it is an instinct: no trial has ever tested a standardized fruiting-body capsule at 1–3 g against placebo for anything.
What would have to be true, and how you would know it was not
1. HbA1c, and this is the prediction that cuts against the product. If the metabolic claim were a systemic receptor-mediated effect rather than fiber viscosity, a label dose should register on the three-month glucose average. Predict it does not: HbA1c moving by less than 0.2 percentage points at 1–3 g/day over 12 weeks, which is inside assay and biological noise. A fall of 0.3 points or more with diet, weight and training genuinely unchanged would be a new result, because no adequately powered human trial has shown it.
2. If the immune mechanism is Dectin-1 priming, the shape of the benefit is fixed and testable. Receptor-driven innate priming changes how fast an infection is handled, not whether the virus lands. So the prediction is a shorter illness rather than a rarer one: days from first symptom to normal should shrink while the number of episodes stays put. A product that appears to reduce episode count and not duration is doing something other than what this mechanism describes.
3. The dose prediction nobody will like. Because the only human dose ladder was non-monotonic Deng 2009, predict that doubling the dose does not double anything, and may reverse it. If you are going to run this on yourself, run one dose for a full season rather than escalating — escalation on a non-monotonic curve generates uninterpretable data.
What will fool you: a hypoglycemic episode on insulin or a sulfonylurea reads as “it works” and is in fact the interaction in the safety section below. That is the one effect of this product most likely to be noticed, and it is not a benefit.
What nobody has tested yet
The trained-immunity assay has never been run on a mushroom supplement. It is not exotic: draw whole blood before and after four weeks, stimulate the monocytes ex vivo with a standard agonist, and measure TNF and IL-6 output. Reprogrammed monocytes produce more Quintin 2012, and the metabolic signature behind that — a shift to aerobic glycolysis — is itself measurable Cheng 2014. This is a blood draw and a plate reader, it is the direct readout of the mechanism the product is sold on, and no maitake study has ever done it.
Nobody has taken Deng's dose ladder past 5 mg/kg. The curve turned over inside the tested range Deng 2009 and the shelf dose is above the range. Extending it by two more steps would tell you whether the doses people actually swallow sit on the rising or the falling limb, and it would take one small trial.
Nobody has genotyped anyone. If Dectin-1 is the receptor, people who signal poorly through it should be non-responders Mata-Martinez 2022. No supplement trial in this category has ever collected a CLEC7A genotype, so the most obvious source of responder variation has never been looked at.
And nobody has separated the fiber from the receptor. Maitake against a viscosity-matched inert fiber, glucose and insulin measured after a standard meal, is a one-day crossover experiment that would settle whether the metabolic half of this product is pharmacology or porridge.
Maitake — its own safety story, not its category's
There is no upper limit and nothing has been set to establish one. What bounds the dose in practice is gut tolerance of a fermentable polysaccharide, and the human record consists of 34 people for 3 weeks Deng 2009. Anyone quoting a safe long-term dose is quoting a habit.
The interaction that actually matters is glucose, and it is additive. Insulin and sulfonylureas can be pushed into hypoglycemia by anything that lowers blood sugar independently. The honest framing is two-sided: the evidence that maitake lowers glucose in humans at label doses is thin, and if it does work it works on top of the drug rather than instead of it. If you take either, test before and after rather than assuming a herb is too weak to matter.
Immunosuppressants and transplant, argued from the mechanism rather than from a category warning. Dectin-1 signaling terminates on NF-kappaB Mata-Martinez 2022. Calcineurin inhibitors, corticosteroids and most transplant regimens exist to hold that same node down. Taking a product whose entire proposed action is switching it on, while paying for a drug that switches it off, is not a theoretical conflict — it is the same transcription factor in both sentences.
The finding that belongs in a safety section and is always printed as a benefit. In the one human dose-ranging trial, some intermediate doses suppressed immune measures rather than raising them Deng 2009. “Take a bit more to be safe” is therefore not a conservative move on this product; it is a move to an untested part of a curve that has already been shown to bend.
Mushroom allergy is a genuine exclusion. Autoimmune disease is a reason to decide deliberately rather than drift into daily use.
Sources read for this page
- Wu JY, et al. Bioactive Ingredients and Medicinal Values of Grifola frondosa (Maitake). Foods 2021 · PMID 33466429
- Deng G, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. Journal of Cancer Research and Clinical Oncology 2009 · PMID 19253021
- Mata-Martinez P, et al. Dectin-1 Signaling Update: New Perspectives for Trained Immunity. Frontiers in Immunology 2022 · PMID 35237264
- De Marco Castro E, et al. beta-1,3/1,6-Glucans and Immunity: State of the Art and Future Directions. Molecular Nutrition & Food Research 2021 · PMID 32223047
- Quintin J, Saeed S, et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host & Microbe 2012 · PMID 22901542
- Cheng SC, Quintin J, et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014 · PMID 25258083
How you would know if it worked
Maitake is sold for two things and only one of them can be tested inside a season. The immune claim is an episode count that would need a whole winter and a comparison group you do not have. The blood-sugar claim is a number: HbA1c averages roughly three months of glucose and does not care how you felt about any of it, and fasting insulin shows whether the pancreas is working harder to hold that average steady. If you are buying the D-fraction for metabolic reasons, draw both first, run it twelve weeks, and let the average answer. If neither moved, the metabolic half did not land for you.
- HbA1c (Hemoglobin A1c) Retest: Every 3 months (matches red cell lifespan).
- Fasting Insulin Retest: Every 3–6 months, or 8–12 weeks after an intervention.
The cheapest panel carrying HbA1c (Hemoglobin A1c) and at least one other of these is Am I Prediabetic?, at $19 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Maitake — safety & side effects
- GI upset is the main report.
- Lowers blood glucose — additive with insulin and sulfonylureas, and capable of causing hypoglycemia. Mild antiplatelet and blood-pressure lowering activity.
- Avoid with mushroom allergy.
The same on every page it applies to. Read it here; it is not repeated research.
- Immunostimulant — caution with autoimmune disease and with immunosuppressants, including after a transplant. Stimulating an immune system that is already attacking you is the wrong direction, and 'natural' does not change that.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Maitake in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Maitake
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | White cells and their differential — the actual immune measurement |
| Vitamin D (25-Hydroxy) | The deficiency with the most credible immune evidence |
| Zinc, Plasma | Real deficiency impairs immune function; excess doesn't help |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney, since 'detox' is what those two organs do |
The Frequent Illness & Immune Resilience panel covers these in one order — 8 markers, $97.65 with the discount applied.
Check results you already have → · All 103 markers A–Z
Maitake — frequently asked questions
What is Maitake?
A medicinal mushroom (beta-glucan 'D-fraction') used for immune support and healthy blood sugar.
What is the suggested dose of Maitake?
1–3 g extract daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Maitake dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Maitake?
Coach Cam sources Maitake from vetted, top-rated brands on iHerb — use the buy link on this page.
What Maitake is used for
Maitake appears under 1 goal in the goal router.
Related Immune & Detox supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.